Viewing Study NCT03971734

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 2:21 AM

Ignite Modification Date: 2026-01-06 @ 8:04 AM

Study NCT ID: NCT03971734

Status: TERMINATED

Last Update Posted: 2023-10-06

First Post: 2019-05-31

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module